EUVIMEDEUVIMED entdecken
Crossref

Discovery of piperazine‐tethered N‐heterocycle derivatives as anticancer agents

Young Hee Lee, Sanha Lee, Jaeuk Sim, Eun Sol Jo, Jae‐Kyung Jung, Soonsil Hyun, Jae‐Hwan Kwak

Bulletin of the Korean Chemical Society · 2026-03 · 47 (3) · 333-341

DOI: 10.1002/bkcs.70101 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bulletin of the Korean Chemical Society, online erschienen am 24.02.2026. Verfasst von Young Hee Lee und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: National Research Foundation of Korea.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Deregulated cell proliferation is a hallmark of carcinogenesis. To develop effective anticancer agents, extensive efforts have been directed toward identifying key regulators of the cell cycle. The piperazine moiety has been reported to possess diverse biological activities; hence, a novel series of piperazine‐based compounds was designed and synthesized as potential anticancer agents. A total of 72 piperazine derivatives were synthesized, and their chemical structures were confirmed by spectral analysis. The in vitro cytotoxic activities of all compounds were evaluated against three human colon tumor cell lines (LS513, WiDR, and HCT‐115). Eight representative compounds showing marked cytotoxicity were further tested against five additional human cancer cell lines: A549 (non‐small cell lung), SK‐OV‐3 (ovarian), HCT‐15 (colon), XF‐498 (CNS), and SK‐MEL‐2 (melanoma). Among them, compounds 1B and 4A exhibited potent cytotoxicity with IC 50 values lower than those of standard reference drugs paclitaxel, colchicine, and doxorubicin. Mechanistic investigations revealed that these compounds induced cell‐cycle arrest at the G 2 /M phase, as evidenced by flow cytometric analysis. Particularly, compound 1B acts as a mitotic inhibitor and may serve as a promising lead structure for the development of new anticancer agents.

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Lee, Y. H., Lee, S., Sim, J., Jo, E. S., Jung, J., Hyun, S., & Kwak, J. (2026). Discovery of piperazine‐tethered N‐heterocycle derivatives as anticancer agents. Bulletin of the Korean Chemical Society, 47(3), 333-341. https://doi.org/10.1002/bkcs.70101

Vancouver

Lee YH, Lee S, Sim J, Jo ES, Jung J, Hyun S, et al. Discovery of piperazine‐tethered N‐heterocycle derivatives as anticancer agents. Bulletin of the Korean Chemical Society. 2026;47(3):333-341. doi:10.1002/bkcs.70101

BibTeX
@article{Lee2026,
  author = {Lee, Young Hee and Lee, Sanha and Sim, Jaeuk and Jo, Eun Sol and Jung, Jae‐Kyung and Hyun, Soonsil and Kwak, Jae‐Hwan},
  title = {Discovery of piperazine‐tethered N‐heterocycle derivatives as anticancer agents},
  journal = {Bulletin of the Korean Chemical Society},
  year = {2026},
  volume = {47},
  number = {3},
  pages = {333--341},
  doi = {10.1002/bkcs.70101}
}
Kostenlos starten →